Table 2.
Unit costs.
|
|
Base | Deterministic rangea | Probabilistic distribution | Comment/source | ||
| Provider costsb |
|
|
|
|
||
| MOTIFc intervention costs (per participant) |
|
|
||||
|
|
Airtime: voice messages | 0.79 | 0.39-1.18 | Gamma | Actual costs from the MOTIF study | |
|
|
Airtime: outgoing phone calls | 2.16 | 1.08-3.25 | Gamma | Actual costs from the MOTIF study | |
|
|
Computer | 1.34 | 0.67-2.01 | Gamma | Actual costs from the MOTIF study | |
|
|
Phone | 0.2 | 0.1-0.3 | Gamma | Actual costs from the MOTIF study | |
| Family planning service commodities |
|
|
||||
|
|
Oral contraceptive pill (one cycle) | 0.29 | 0.15-0.44 | Gamma | Direct cost reported by an MSICe clinic | |
|
|
IUDd | 0.4 | 0.2-0.6 | Gamma | Direct cost reported by an MSIC clinic | |
|
|
Medical abortion (Mariprist) | 0.7 | 0.35-1.05 | Gamma | Direct cost reported by an MSIC clinic | |
|
|
Surgical abortion | 5 | 2.5-7.5 | Gamma | Personal communication with MOTIF trial authors | |
|
|
Injectable contraceptive (one dose) | 0.5 | 0.25-0.75 | Gamma | Direct cost reported by an MSIC clinic | |
|
|
Implanted subdermal contraceptive (Femplant) | 8 | 4-12 | Gamma | Direct cost reported by an MSIC clinic | |
|
|
Long-acting contraceptive device removal | 3 | 1.5-4.5 | Gamma | Personal communication with MOTIF trial authors | |
| Personnel (hourly) |
|
|
|
|
||
|
|
Midwife/health care service provider | 2.36 | 1.18-3.54 | Gamma | Direct cost reported by an MSIC clinic | |
|
|
Counsellor | 2.52 | 1.26-3.78 | Gamma | Direct cost reported by an MSIC clinic | |
| User costsa |
|
|
||||
| Direct costs |
|
|
|
|
||
|
|
IUDd insertion | 5 | 2.5-7.5 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Implant insertion | 25 | 12.5-37.5 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Injectable (MSIC clinic) | 1 | 0.5-1.5 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Injectable (pharmacy) | 0.73 | 0.37-1.1 | Gamma | Direct price to users reported by a local pharmacy | |
|
|
Oral contraceptive pill (MSIC clinic) | 0.4 | 0.2-0.6 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Oral contraceptive pill (pharmacy) | 0.37 | 0.19-0.56 | Gamma | Direct price to users reported by a local pharmacy | |
|
|
IUD removal | 2 | 1-3 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Implant removal | 3.75 | 1.8-5.63 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Repeat abortion (surgical) | 25 | 12.5-37.5 | Gamma | Direct price to users reported by an MSIC clinic | |
|
|
Repeat abortion (medical) | 20 | 10-30 | Gamma | Direct price to users reported by an MSIC clinic | |
| Mobile phone |
|
|
||||
|
|
Airtime to call a clinic/hotline (per min) | 0.07 | 0.04-0.11 | Gamma | Advertised cross-network charge in Cambodia | |
| Transport |
|
|
|
|
||
|
|
Motorbike travel (per km) | 0.22 | 0.11-0.33 | Gamma | Data from Rozemuller et al [23] | |
|
|
Average distance from clinic to home (km) | 38.2 | 30.1-46.3f | Gamma | Data from the MOTIF study | |
| Indirect costs |
|
|
|
|
||
|
|
Gross national income per capita | 2534 | 2280.6-2787.4g | Gamma | World Bank development data [22] | |
|
|
Gross daily income per capita | 6.9 | 6.2-7.6g | Gamma | World Bank development data [22] | |
|
|
Repeat abortion (total household indirect cost) | 5.07 | 2.54-7.61 | Gamma | Data from Potdar et al [24] | |
aThe range used for deterministic analysis was 50% above and below the base case estimate unless otherwise indicated. This range was then assumed to represent the 95% confidence interval of the distribution indicated for probabilistic sensitivity analysis.
bUnit costs were combined to calculate the service level costs used in the model.
cMOTIF: MObile Technology for Improved Family planning.
dIUD: intrauterine device.
eMSIC: Marie Stopes International Cambodia.
fRange used is the 95% confidence interval from MOTIF data.
gRange used is 10% above and below the base case estimate.